GLP-1 receptor agonist
Semaglutide companies
Answer
Public registers name 7 licence holders, 43 bulk ingredient labelers, 6 US labelers, 312 trial sponsors, 138 companies with an FDA warning letter and 16 recalling firms for Semaglutide.
Each row is what a register states. A company named here is not endorsed or accused by this site.
MARKETING AUTHORISATION HOLDER
7 companies
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| APOTEX INC | APO-SEMAGLUTIDE INJECTION (DIN 02568012), Marketed Regulator Health Canada APO-SEMAGLUTIDE INJECTION (DIN 02568020), Marketed Regulator Health Canada SEVMIA (DIN 02569582), Approved Regulator Health Canada |
|---|---|
| ASPEN PHARMACARE CANADA INC. | ASPEN-SEMAGLUTIDE (DIN 02569930), Approved Regulator Health Canada ASPEN-SEMAGLUTIDE (DIN 02569949), Approved Regulator Health Canada SEMAGLUTIDE INJECTION (DIN 02570912), Approved Regulator Health Canada and 1 more entries |
| DR REDDY'S LABORATORIES LTD | SEMAGLUTIDE INJECTION (DIN 02567806), Marketed Regulator Health Canada SEMAGLUTIDE INJECTION (DIN 02567814), Marketed Regulator Health Canada |
| Novo Nordisk A/S | Kayshild (EMEA/H/C/006426), Authorised Regulator EMA Kyinsu (EMEA/H/C/006279), Authorised Regulator EMA Ozempic (EMEA/H/C/004174), Authorised Regulator EMA and 2 more entries |
| NOVO NORDISK AS | OZEMPIC 0.25 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 04668/0331, Authorised Regulator MHRA OZEMPIC 0.5 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 04668/0332, Authorised Regulator MHRA OZEMPIC 1 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 04668/0333, Authorised Regulator MHRA and 17 more entries |
| NOVO NORDISK CANADA INC | OZEMPIC (DIN 02471469), Marketed Regulator Health Canada OZEMPIC (DIN 02471477), Dormant Regulator Health Canada OZEMPIC (DIN 02523930), Approved Regulator Health Canada and 37 more entries |
| SANDOZ CANADA INCORPORATED | SANDOZ SEMAGLUTIDE (DIN 02571501), Approved Regulator Health Canada SANDOZ SEMAGLUTIDE (DIN 02571528), Approved Regulator Health Canada |
BULK INGREDIENT LABELER
43 companies
Lists the bulk active ingredient with FDA (NDC directory).
| Apicore pharmaceuticals private limited | Semaglutide, BULK INGREDIENT Regulator openFDA |
|---|---|
| Arene Life Sciences Private Limited | semaglutide, BULK INGREDIENT Regulator openFDA |
| Aurisco Pharmaceutical Co.,Ltd | Semaglutide, BULK INGREDIENT Regulator openFDA |
| Bachem AG | Semaglutide, BULK INGREDIENT Regulator openFDA |
| Bills Biotech Pvt. Ltd. | Semaglutide IH, BULK INGREDIENT Regulator openFDA |
| Biocon Limited | Semaglutide, BULK INGREDIENT Regulator openFDA |
| Chatnaa Life Sciences LLC | Semaglutide, BULK INGREDIENT Regulator openFDA |
| Chengdu Brilliant Biopharmaceutical Co., Ltd. | Semaglutide, BULK INGREDIENT Regulator openFDA |
| Chengdu Shengnuo Biopharm Co. Ltd. | Semaglutide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| Chinese Peptide Company | Semaglutide, BULK INGREDIENT Regulator openFDA |
| Chongqing Sintaho Pharmaceutical Co., Ltd. | Semaglutide, BULK INGREDIENT Regulator openFDA |
| Chunghwa Chemical Synthesis & Biotech Co., Ltd. | Semaglutide, BULK INGREDIENT Regulator openFDA |
| Darmerica, LLC | Semaglutide, BULK INGREDIENT Regulator openFDA |
| Dr.Reddys Laboratories Limited | Semaglutide, BULK INGREDIENT Regulator openFDA |
| El-Peptido (Shanghai) Biopharmaceutical Co., Ltd | SEMAGLUTIDE, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| Fujian Genohope Biotech Ltd. | semaglutide, BULK INGREDIENT Regulator openFDA Semaglutide, BULK INGREDIENT Regulator openFDA |
| Hainan Poly Pharm., Co., Ltd. | Semaglutide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| Hetero Drugs Limited | Semaglutide, BULK INGREDIENT Regulator openFDA |
| Hubei JXBio Pharmaceutical Co.,Ltd | Semaglutide, BULK INGREDIENT Regulator openFDA semaglutide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| Hybio Pharmaceutical Co., Ltd. | Semaglutide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| Jilin Qijian Bio-Pharmaceutical Co., Ltd. | Semaglutide, BULK INGREDIENT Regulator openFDA |
| Medisca Inc. | Semaglutide, BULK INGREDIENT Regulator openFDA |
| MSN Life Sciences Private Limited | Semaglutide, BULK INGREDIENT Regulator openFDA |
| NOMIDA LLC | Semaglutide, BULK INGREDIENT Regulator openFDA |
| Novo Nordisk A/S | Semaglutide, BULK INGREDIENT Regulator openFDA |
| Pharma Source Direct, Inc. | Semaglutide, BULK INGREDIENT Regulator openFDA |
| PolyPeptide SA | SEMAGLUTIDE, BULK INGREDIENT Regulator openFDA |
| Qingdao Biopeptek Co., Ltd. | Semaglutide, BULK INGREDIENT Regulator openFDA |
| SCH Global Services Private Limited | Semaglutide, BULK INGREDIENT Regulator openFDA |
| Shanghai Ambiopharm, Inc | Semaglutide, BULK INGREDIENT Regulator openFDA |
| Shenzhen Alvantis Pharma Co., Ltd. | Semaglutide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| SHILPA PHARMA LIFESCIENCES LIMITED | Semaglutide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| Sichuan Jisheng Biopharmaceutical Co.,Ltd | Semaglutide, BULK INGREDIENT Regulator openFDA |
| Sinopep-Allsino Biopharmaceutical Co., Ltd. | Semaglutide, BULK INGREDIENT Regulator openFDA Semaglutide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| Supriya Lifescience Limited | SEMAGLUTIDE, BULK INGREDIENT Regulator openFDA |
| Suzhou Lixin Pharmaceutical Co., Ltd. | semaglutide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| Thaeta Scientific LLC | Semaglutide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| Virtu Pharmako (Zhejiang) Co., Ltd. | semaglutide, BULK INGREDIENT Regulator openFDA |
| Zhejiang Jiuzhou Pharmaceutical Co., Ltd. | Semaglutide, BULK INGREDIENT Regulator openFDA |
| Zhejiang Kingland Pharmaceutical Company Limited | semaglutide, BULK INGREDIENT Regulator openFDA |
Showing 40 of 43.
US LABELER
6 companies
Lists a finished product with FDA (NDC directory); can be a maker, repackager or distributor.
| A-S Medication Solutions | Ozempic, NDA Regulator openFDA OZEMPIC, NDA Regulator openFDA WEGOVY, NDA Regulator openFDA |
|---|---|
| Catalent Indiana, LLC | semaglutide, DRUG FOR FURTHER PROCESSING Regulator openFDA |
| Novo Nordisk A/S | Semaglutide SNAC, DRUG FOR FURTHER PROCESSING Regulator openFDA semaglutide, DRUG FOR FURTHER PROCESSING Regulator openFDA Semaglutide, DRUG FOR FURTHER PROCESSING Regulator openFDA |
| Novo Nordisk Pharmaceutical Industries, LP | Ozempic, NDA Regulator openFDA OZEMPIC, NDA Regulator openFDA RYBELSUS, NDA Regulator openFDA and 1 more entries |
| Novo Nordisk Production Belgium SA | semaglutide, DRUG FOR FURTHER PROCESSING Regulator openFDA Semaglutide, DRUG FOR FURTHER PROCESSING Regulator openFDA |
| Patheon Manufacturing Services LLC | semaglutide, DRUG FOR FURTHER PROCESSING Regulator openFDA |
TRIAL SPONSOR
312 companies
Sponsors registered clinical trials of the peptide.
| Novo Nordisk A/S | 256 registered trials Trial register ClinicalTrials.gov 37 registered trials Trial register EU CTIS |
|---|---|
| Brigham and Women's Hospital | 15 registered trials Trial register ClinicalTrials.gov |
| Eli Lilly & Company | 9 registered trials Trial register ClinicalTrials.gov |
| University of Colorado, Denver | 8 registered trials Trial register ClinicalTrials.gov |
| Region Hovedstaden | 7 registered trials Trial register EU CTIS |
| Mayo Clinic | 6 registered trials Trial register ClinicalTrials.gov |
| Steno Diabetes Center Copenhagen | 3 registered trials Trial register EU CTIS 3 registered trials Trial register ClinicalTrials.gov |
| Yale University | 6 registered trials Trial register ClinicalTrials.gov |
| Rigshospitalet | 5 registered trials Trial register EU CTIS |
| University Health Network, Toronto | 5 registered trials Trial register ClinicalTrials.gov |
| University Medical Centre Ljubljana | 5 registered trials Trial register ClinicalTrials.gov |
| Vanderbilt University Medical Center | 5 registered trials Trial register ClinicalTrials.gov |
| Boehringer Ingelheim | 4 registered trials Trial register ClinicalTrials.gov |
| BrightGene Bio-Medical Technology Co., Ltd. | 4 registered trials Trial register ClinicalTrials.gov |
| Merck Sharp & Dohme LLC | 1 registered trial Trial register EU CTIS 3 registered trials Trial register ClinicalTrials.gov |
| The University of Texas Health Science Center, Houston | 4 registered trials Trial register ClinicalTrials.gov |
| AstraZeneca | 3 registered trials Trial register ClinicalTrials.gov |
| Chinese University of Hong Kong | 3 registered trials Trial register ClinicalTrials.gov |
| Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 3 registered trials Trial register ClinicalTrials.gov |
| Imperial College London | 3 registered trials Trial register ClinicalTrials.gov |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 3 registered trials Trial register ClinicalTrials.gov |
| The Cleveland Clinic | 3 registered trials Trial register ClinicalTrials.gov |
| University College Dublin | 1 registered trial Trial register EU CTIS 2 registered trials Trial register ClinicalTrials.gov |
| University of Minnesota | 3 registered trials Trial register ClinicalTrials.gov |
| UZ Leuven | 3 registered trials Trial register EU CTIS |
| Washington University School of Medicine | 3 registered trials Trial register ClinicalTrials.gov |
| Aarhus University Hospital | 1 registered trial Trial register EU CTIS 1 registered trial Trial register ClinicalTrials.gov |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2 registered trials Trial register ClinicalTrials.gov |
| Anders Fink-Jensen, MD, DMSci | 2 registered trials Trial register ClinicalTrials.gov |
| Beijing Chao Yang Hospital | 2 registered trials Trial register ClinicalTrials.gov |
| Bispebjerg Hospital | 1 registered trial Trial register EU CTIS 1 registered trial Trial register ClinicalTrials.gov |
| Camurus AB | 2 registered trials Trial register EU CTIS |
| Carnot Laboratories | 2 registered trials Trial register ClinicalTrials.gov |
| Children's Hospital Medical Center, Cincinnati | 2 registered trials Trial register ClinicalTrials.gov |
| China-Japan Friendship Hospital | 2 registered trials Trial register ClinicalTrials.gov |
| Chinese Academy of Sciences | 2 registered trials Trial register ClinicalTrials.gov |
| Dasman Diabetes Institute | 2 registered trials Trial register ClinicalTrials.gov |
| Eli Lilly & Co. | 2 registered trials Trial register EU CTIS |
| Fudan University | 2 registered trials Trial register ClinicalTrials.gov |
| Fujian Shengdi Pharmaceutical Co., Ltd. | 2 registered trials Trial register ClinicalTrials.gov |
Showing 40 of 312.
WARNING LETTER RECIPIENT
138 companies
Received an FDA warning letter naming the peptide.
| 24HrDoc, Inc. dba 24HrDoc | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
|---|---|
| Alan Health Technologies Inc. dba Alan | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
| All American Wellness | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Altru Telehealth, LLC dba Altru Telehealth | False & Misleading Claims/Misbranded (Telehealth), 2026-06-08 Regulator FDA warning letters |
| Amazing Meds | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Amie Health, Inc. dba Amie | False & Misleading Claims/Misbranded (Telehealth), 2026-06-08 Regulator FDA warning letters |
| AnuMed International, LLC | Finished Pharmaceutical/Unapproved New Drug/Adulterated/Misbranded, 2024-08-20 Regulator FDA warning letters |
| Apothecary Pharma, LLC | Compounding Pharmacy/Adulterated Drug Products, 2025-12-01 Regulator FDA warning letters |
| ASN-LABS | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Aspen Aesthetics dba Fifty 410 | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
| Belle Health LLC dba Belle | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
| Better Health Labs, Inc. dba Measured | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
| Bioverse, Inc. dba Bioverse | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Bliv Wellness LLC dba Bliv | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
| BluefitMD | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
| Body Good Studio | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Boothwyn Pharmacy LLC | Compounding Pharmacy/Adulterated Drug Products, 2026-01-16 Regulator FDA warning letters |
| Canada Med Stop | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| cheaptrustedpharmacy.com | Notice of Unlawful Sale of Unapproved Drugs to United States Consumers Over the Internet, 2025-07-29 Regulator FDA warning letters |
| Chengdu Brilliant Biopharmaceutical Co., Ltd. | CGMP/Finished Pharmaceuticals/Adulterated, 2025-09-11 Regulator FDA warning letters |
| Clover Meds LLC dba Clover Meds | False & Misleading Claims/Misbranded (Telehealth), 2026-06-08 Regulator FDA warning letters |
| Curex | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| D&H Medical Services | False & Misleading Claims/Misbranded (Telehealth), 2026-06-08 Regulator FDA warning letters |
| Deluxe IV Aesthetics PLLC dba Deluxe IV and Aesthetics | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
| Dr. Gater’s Weight Loss & Wellness | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Dripgym Mobile Parent, LLC dba Amp Health | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
| EA WORKS Limited Liability Company dba Trust Labs | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Eden Health International Inc. dba Eden | False & Misleading Claims/Misbranded (Telehealth), 2026-06-08 Regulator FDA warning letters |
| Eli Lilly & Company | False & Misleading Claims/Misbranded, 2025-09-09 Regulator FDA warning letters |
| Elite Health Center | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Empower Clinic Services, LLC dba Empower Pharmacy | CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug, 2026-09-18 Regulator FDA warning letters |
| Expert Aesthetics | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Ezra Holdco LLC dba Ezra | False & Misleading Claims/Misbranded (Telehealth), 2026-06-08 Regulator FDA warning letters |
| Fancy Meds, LLC dba Fancy Meds | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| FITISH | False & Misleading Claims/Misbranded (Telehealth), 2026-06-08 Regulator FDA warning letters |
| FitRX, LLC dba AM RX | False & Misleading Claims/Misbranded (Telehealth), 2026-06-08 Regulator FDA warning letters |
| FitRX, LLC dba FitRx | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
| FitRX, LLC dba Zealthy | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| FWD Care, Inc. dba FWD | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Genesis Health International Inc. dba Genesis | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
Showing 40 of 138.
RECALLING FIRM
16 companies
Recalled a product naming the peptide (FDA enforcement report).
| AEQUITA PHARMACY | Class II recall, Ongoing, 2025-08-13 Regulator openFDA |
|---|---|
| Apollo Care, LLC | Class II recall, Ongoing, 2026-08-19 Regulator openFDA |
| Boothwyn Pharmacy LLC | Class II recall, Ongoing, 2025-09-10 Regulator openFDA |
| Cardinal Health Inc. | Class II recall, Ongoing, 2025-05-07 Regulator openFDA Class II recall, Terminated, 2021-06-02 Regulator openFDA |
| Carolina Infusion | Class II recall, Completed, 2022-09-21 Regulator openFDA |
| GenoGenix LLC | Class II recall, Ongoing, 2025-10-15 Regulator openFDA |
| Harbin Jixianglong Biotech Co., Ltd. | Class II recall, Ongoing, 2026-03-11 Regulator openFDA |
| New Life Pharma LLC | Class II recall, Ongoing, 2026-03-11 Regulator openFDA |
| Novo Nordisk Inc | Class II recall, Ongoing, 2026-01-07 Regulator openFDA Class II recall, Terminated, 2021-04-21 Regulator openFDA |
| PAYLESS COMPOUNDERS, LLC | Class II recall, Ongoing, 2026-04-22 Regulator openFDA |
| Pharmacy Innovations | Class II recall, Terminated, 2023-02-01 Regulator openFDA |
| Pharmacy Plus, Inc. dba Vital Care Compounder | Class II recall, Ongoing, 2022-11-09 Regulator openFDA Class II recall, Ongoing, 2023-04-26 Regulator openFDA |
| ProRx LLC | Class II recall, Ongoing, 2024-09-11 Regulator openFDA Class II recall, Ongoing, 2025-11-05 Regulator openFDA |
| Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) | Class II recall, Ongoing, 2025-07-02 Regulator openFDA |
| TMC Acquisition LLC dba Tailor Made Compounding | Class II recall, Ongoing, 2022-07-20 Regulator openFDA |
| TMC Acquisitions LLC dba Tailor Made Compounding | Class II recall, Terminated, 2023-08-30 Regulator openFDA |
Every company across all peptides: companies. Names are matched only when identical apart from case and punctuation, so one group can appear under two spellings.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.